
Acta Crystallographica, Section C: Crystal Structure Communications p. 2000 - 2002 (1999)
Update date:2022-09-26
Topics:
Banerjee, Sangeeta
Bhattacharyya, Sibaprasad
Chakraborty, Indranil
Dirghangi, Bimal Kumar
The title compound, (4-aminophenylimido)trichloro[2-(4-chlorophenyliminomethyl)pyridine]rhenium(V), [Re-(NC6H4NH2)Cl3(ClA)], where ClA is N-(p-chlorophenyl)pyridine-2-aldimine (p-ClC6H4N=CHC5H4N), was synthesized by reacting the corresponding oxo complex, [ReOCl3(ClA)], or the corresponding phosphine oxide complex, [Re(OPPh3)Cl3(ClA)], with p-phenylenediamine in toluene. The structure determination revealed that the ReCl3N3 coordination sphere is severely distorted from octahedral geometry and that it has a meridional ReCl3 fragment. The Re - N - C angle in the imide part is nearly linear and the Re - Nimide bond can be considered to be triple bond in character. The Re atom is distorted towards the imide N atom by 0.29 A from the equatorial Cl3Nimine plane. The Re - Npyridine bond is longer by 0.15 A than the Re - Nimine bond due to the trans influence of the imide fragment.
Hefei Lifeon Pharmaceutical Co., Ltd.
Contact:+86-551-65328450
Address:No522 Wangjiang West Road
Daqing E-shine Chemical Co.,LTD
Contact:0086-024-31285112
Address:Hongweiyuan area, Ranghulu district
Wuhan Sunrise Pharmaceutical Technology Co., Ltd
Contact:+86-27-83314682
Address:Room 340, New material Industrial base No.17, Gu Tian Five Lu , Qiaokou District, Wuhan , China
Jinan Jiaquan Chemical Co.,Ltd
Contact:+86-531-62318366
Address:Room 502 of Yidonghuayuan No.601 Huaxin Road Licheng District Jinan China
Hefei Lifeon Pharmaceutical Co., Ltd.
Contact:+86-551-65328450
Address:No522 Wangjiang West Road
Doi:10.1055/s-2006-947334
(2006)Doi:10.1016/S0957-4166(99)00517-0
(1999)Doi:10.1016/j.bmcl.2020.127374
(2020)Doi:10.1021/om990850r
(2000)Doi:10.1016/j.bmcl.2004.11.001
(2005)Doi:10.1080/00397910008087311
(2000)